Log in to search using one of your social media accounts:

 

ATS: Bronchial Thermoplasty Has Lasting Benefits for Asthma
Reduction in severe exacerbations, hospitalizations, ER visits in first and second year of follow - up (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 25, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Allergy, Pharmacy, Pulmonology, Conference News, Source Type: news

The NET effect of viral-triggered asthma
(Source: ScienceNOW)
Source: ScienceNOW - May 25, 2017 Category: Science Authors: Kelly, P. N. Tags: twil Source Type: news

Anti-IgE Drug Might Change Asthma Course (CME/CE)
(MedPage Today) -- Lung improvement observed in children treated with omalizumab (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 24, 2017 Category: Allergy & Immunology Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 24, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Feds charge ex-Medicare employees with insider trading Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis i...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Early-onset Atopic Dermatitis Tied to Increased Risk of Food Allergies, Asthma Early-onset Atopic Dermatitis Tied to Increased Risk of Food Allergies, Asthma
Children who develop atopic dermatitis before age two are much more likely to develop asthma and food allergy by age six, according to a new study identifying four different phenotypes of atopic dermatitis in childhood.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 24, 2017 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference MARLBOROUGH, Mass., May 24, 2017 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) today announced positive results ... Devices Boston Scientific, Bronchial Thermoplasty, Asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2017 Category: Pharmaceuticals Source Type: news

Boston Scientific ’ s post-approval Alair study shows long-term asthma improvement
Patients treated with the Alair device made by Boston Scientific (NYSE:BSX) showed long-term improvement in controlling their asthma, according to a post-approval study released today at the annual meeting of the American Thoracic Society in Washington. The Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. Boston acquired the technology when it paid $194 million in cash for Asthmatx in 2010, shortly after that company won 510(k) clearance from the FDA for Alair. The deal also included some $250 million in pote...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Respiratory Wall Street Beat Boston Scientific Source Type: news

ATS Roundup: Emulate models viral infection in “asthma-on-a-chip”
Emulate‘s small airway-lung chip could help researchers study viral-induced exacerbations of asthma, according to data presented this week at the American Thoracic Society’s annual meeting. The studies were conducted as part of the company’s partnership with (NYSE:MRK). The collaborative project was designed to enable development of new anti-inflammatory treatments for patients with asthma, according to Emulate. Get the full story at our sister site, Drug Delivery Business News.   The post ATS Roundup: Emulate models viral infection in “asthma-on-a-chip” appeared first on MassDevice....
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Emulate Inc Merck Source Type: news

Tiotropium Add-on Tx Improved Lung Function in Kids with Asthma
(MedPage Today) -- Disease phenotype had no impact on treatment (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 24, 2017 Category: Allergy & Immunology Source Type: news

AstraZeneca ’s Phase III trial shows benralizumab minimises OCS use in asthma patients
AstraZeneca has reported positive results from its Phase III clinical trial of benralizumab in combination with standard-of-care treatment for patients with severe asthma. (Source: Drug Development Technology)
Source: Drug Development Technology - May 23, 2017 Category: Pharmaceuticals Source Type: news

Stress Marker in Infant Urine May Predict Asthma (CME/CE)
(MedPage Today) -- Higher F2-isoprostane during lung infection linked to later wheeze (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2017 Category: Allergy & Immunology Source Type: news

ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma
Significant 75 percent reduction in median final oral glucocorticoid doses from baseline (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Conference News, Source Type: news

AstraZeneca asthma shot hits goal but diabetes drug lags rival
LONDON (Reuters) - AstraZeneca's experimental injection for severe asthma cut substantially the need for patients to take problematic oral steroid drugs in a late-stage study, boosting hopes for a medicine that is expected to reach the market later this year. (Source: Reuters: Health)
Source: Reuters: Health - May 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Spiriva Respimat improves breathing in asthma
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - May 23, 2017 Category: Research Source Type: news

Benralizumab Associated with Less Use of Oral Glucocorticoids in Severe Asthma (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD The investigational monoclonal antibody benralizumab is associated with reduced oral glucocorticoid use in patients with severe asthma, according to a phase 3, industry-funded … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 22, 2017 Category: Primary Care Source Type: news

Novel Monoclonal Antibody Cuts Steroid Use in Severe Asthma (CME/CE)
(MedPage Today) -- Benralizumab reduced median oral steroid use by 75% (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - May 22, 2017 Category: Consumer Health News Source Type: news

Hay fever mapping? There ’s an app for that | Letter from Dr Sheena Cruickshank
Dr Sheena Cruickshank on how ‘citizen sensors’ can help scientists to learn of how pollen, weather and pollution interact to trigger allergy symptomsSeasonal allergies, such as hay fever and allergic asthma, are on the rise in the UK as your article (First hay fever map of Britain offers some relief to sufferers, theguardian.com, 20 May) rightly points out, with up to one in four people now experiencing symptoms each year. However, these are complex conditions, and just mapping pollen levels does not tell the full story in allowing accurate prediction of allergy symptoms. Many people will react to multiple thin...
Source: Guardian Unlimited Science - May 22, 2017 Category: Science Authors: Letters Tags: Hay fever Allergies Society Apps Technology iPhone iOS Software Android Immunology Medical research Biochemistry and molecular biology Science Source Type: news

Severe asthma drug shows AstraZeneca promise beyond cancer
LONDON (Reuters) - AstraZeneca's experimental injection for severe asthma cut substantially the need for patients to take problematic oral steroids drugs in a late-stage study, boosting hopes for a medicine that is expected to reach the market later this year. (Source: Reuters: Health)
Source: Reuters: Health - May 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Air pollution warning: Exposure 'can cause asthma to develop in unborn children'
PREGNANT mothers have been warned that exposure to high levels of air pollution can cause asthma to develop in their unborn child. (Source: Daily Express - Health)
Source: Daily Express - Health - May 22, 2017 Category: Consumer Health News Source Type: news

KIT Inhibition by Imatinib Helps Severe Refractory Asthma
Improvement in airway hyperresponsiveness seen with imatinib versus placebo (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 22, 2017 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Emergency Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Traffic pollution linked to aging and asthma in children
Youngsters had a specific type of DNA damage called telomere shortening - the main cause of premature aging - say Californian researchers. (Source: the Mail online | Health)
Source: the Mail online | Health - May 22, 2017 Category: Consumer Health News Source Type: news

Could Cancer Drug Gleevec Help With Severe Asthma?
Title: Could Cancer Drug Gleevec Help With Severe Asthma?Category: Health NewsCreated: 5/19/2017 12:00:00 AMLast Editorial Review: 5/22/2017 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 22, 2017 Category: Respiratory Medicine Source Type: news

Graphene-based sensor could improve evaluation, diagnosis and treatment of asthma
(Rutgers University) Rutgers University-New Brunswick scientists have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks and improve the management of asthma and other respiratory diseases, preventing hospitalizations and deaths. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2017 Category: International Medicine & Public Health Source Type: news

How Much Peanut Butter Should He Take?
Discussion Peanut allergy is an increasing problem with ~2% prevalence in the United States. It is also the leading cause of food-related death. The LEAP trial (Learning Early about Peanut Allergy trial) was a randomized trial of early introduction of peanut foods to try to prevent peanut allergy. It found a significant decrease in peanut allergy at 60 months of age with early introduction of peanut foods to infants. This finding occurred in participants with baseline negative skin testing (13.7% in peanut avoidance group versus 1.9% in peanut consumption group) or those with measureable peanut skin testing at study entry ...
Source: PediatricEducation.org - May 22, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Could Cancer Drug Gleevec Help With Severe Asthma?
A leukemia drug might also effectively treat severe asthma, a small-scale clinical trial suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 19, 2017 Category: Consumer Health News Source Type: news

Cancer drug Gleevec may help with severe asthma
A leukemia drug might also effectively treat severe asthma, a small-scale clinical trial suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 19, 2017 Category: Consumer Health News Source Type: news

Could Cancer Drug Gleevec Help With Severe Asthma?
Small study suggests a new approach might one day help those with uncontrolled lung disease (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 19, 2017 Category: Respiratory Medicine Tags: Nursing, Oncology, Pharmacy, Pulmonology, Asthma, Research, News, Source Type: news

Is There a Role for Weight Loss in Obese Patients With Asthma? Is There a Role for Weight Loss in Obese Patients With Asthma?
Extra pounds spell trouble for asthma patients. Dr Gross reviews the literature on next steps.Medscape Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 19, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Viewpoint Source Type: news

Acid-Suppressing Drugs May Blunt Corticosteroid Response in Asthma Acid-Suppressing Drugs May Blunt Corticosteroid Response in Asthma
Acid-suppression medications are associated with changes in the airway microbiome in patients with asthma, and these changes may affect corticosteroid response, new research suggests.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 19, 2017 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Could Cancer Drug Gleevec Help with Severe Asthma?
Small study suggests a new approach might one day help those with uncontrolled lung disease Source: HealthDay Related MedlinePlus Pages: Asthma, Leukemia, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 19, 2017 Category: Consumer Health News Source Type: news

Could Cancer Drug Gleevec Help With Severe Asthma?
FRIDAY, May 19, 2017 -- A leukemia drug might also effectively treat severe asthma, a small-scale clinical trial suggests. Gleevec (imatinib) reduced the " twitchiness " of airways, making them less likely to reflexively constrict when exposed to an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 19, 2017 Category: General Medicine Source Type: news

Hikma shares hit after cutting sales forecasts
Warning follows FDA decision to block generic version of GSK asthma drug (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 19, 2017 Category: Pharmaceuticals Source Type: news

Researchers create a T-shirt that monitors the wearer's breathing rate in real time
Researchers have created a smart T-shirt that monitors the wearer's respiratory rate in real time. This innovation paves the way for manufacturing clothing that could be used to diagnose respiratory illnesses or monitor people suffering from asthma, sleep apnea, or chronic obstructive pulmonary disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 18, 2017 Category: Science Source Type: news

NIH research improves health for people with asthma
May is Asthma Awareness Month, and the National Institutes of Health is finding solutions to improve health of those who have asthma. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - May 18, 2017 Category: Environmental Health Source Type: news

Researchers create a T-shirt that monitors the wearer's breathing rate in real time
(Universit é Laval) Researchers at Universit é Laval's Faculty of Science and Engineering and its Center for Optics, Photonics, and Lasers have created a smart T-shirt that monitors the wearer's respiratory rate in real time. This innovation paves the way for manufacturing clothing that could be used to diagnose respiratory illnesses or monitor people suffering from asthma, sleep apnea, or chronic obstructive pulmonary disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2017 Category: International Medicine & Public Health Source Type: news

Proof-of principle study finds imatinib improves symptoms for patients with severe asthma
In a new, proof-of-principle study researchers have found that targeting the mast cells with imatinib, a drug used to effectively treat certain forms of cancer, improved airway hyperresponsiveness, a measure of the sensitivity of the airway, and decreased the number of mast cells present in the airway. Treatment also produced a small improvement in airway function. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 17, 2017 Category: Science Source Type: news

Asthma Biologic, Rally Among ATS Highlights
(MedPage Today) -- Attendees to march on Capitol Hill, hear benralizumab phase III results (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 17, 2017 Category: Allergy & Immunology Source Type: news

Proof-of Principle Study Finds Imatinib Improves Symptoms for Patients with Severe Asthma
In a new, proof-of-principle study, researchers found that targeting the mast cells with imatinib, a drug used to effectively treat certain forms of cancer, improved airway hyper responsiveness, and decreased the number of mast cells present. (Source: BWH News)
Source: BWH News - May 17, 2017 Category: Hospital Management Source Type: news

Childhood asthma: How to spot it and manage the condition
SPONSORED. An astonishing 1.1 million young people – that's around one child in every 11 - have the condition that makes breathing so difficult. (Source: the Mail online | Health)
Source: the Mail online | Health - May 16, 2017 Category: Consumer Health News Source Type: news

Officer Overdoses On Fentanyl Just By Brushing It Off Shirt, Police Say
An Ohio police officer suffered a near-fatal drug overdose after he tried to brush what was believed to be powdered fentanyl off his shirt with his bare hand, authorities said. East Liverpool Officer Chris Green had just carried out a traffic arrest of two drug suspects on Friday night. Another officer pointed out the white substance on Green’s shirt, the same substance that was allegedly strewn about in the suspects’ car. “Just out of instinct, he tried to brush it off — not thinking,” Police Capt. Patrick Wright told Youngstown’s WKBN-TV. At that point, Green was no longer wearing...
Source: Healthy Living - The Huffington Post - May 15, 2017 Category: Consumer Health News Source Type: news

Taking Vitamin D for itchy skin, asthma or allergies? Research says its probably POINTLESS
ITCHY skin, asthma and allergies have previously been attributed to low vitamin D levels. But new research says this isn ’t the case. (Source: Daily Express - Health)
Source: Daily Express - Health - May 15, 2017 Category: Consumer Health News Source Type: news

Taking Vitamin D for itchy skin, asthma or allergies? It's probably POINTLESS says researc
ITCHY skin, asthma and allergies have previously been attributed to low vitamin D levels. But new research says this isn ’t the case. (Source: Daily Express - Health)
Source: Daily Express - Health - May 15, 2017 Category: Consumer Health News Source Type: news

Nigeria: 10 Million Nigerians Suffer From Asthma, Says Expert
[Guardian] Prof. Gregory Erhabor, Consultant Pulmonologist, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun on Sunday said more than 10 million Nigerians were suffering from asthma. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 15, 2017 Category: African Health Source Type: news

omalizumab, Xolair
Title: omalizumab, XolairCategory: MedicationsCreated: 5/27/2004 12:00:00 AMLast Editorial Review: 5/15/2017 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 15, 2017 Category: Respiratory Medicine Source Type: news

'Super pollen' hay fever could trigger asthma attacks
Hay fever sufferers are being warned to prepare for the devastating effects of ‘super pollen’. The potent phenomenon could trigger asthma attacks among allergy sufferers. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2017 Category: Consumer Health News Source Type: news

Stress-mitigation interventions for parents did not lessen symptoms among kids with asthma
A $2.2 million, first-of-its kind randomized study found no differences between kids with asthma who received standard care based on National Institutes of Health guidelines compared with kids whose parents received stress-mitigation techniques in addition to evidence-based asthma care. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 12, 2017 Category: Science Source Type: news

Health: EpiPen maker accused of overcharging for asthma drug
Mylan lawsuit. A lawsuit filed Thursday by the Self-Insured Schools of California accuses EpiPen manufacturer Mylan and Sun Pharmaceutical Industries of conspiring to charge higher prices for a generic asthma medication, Axios reported, the second time this year the company has been accused of price gouging. In April, Mylan (NASDAQ-MYL) was named in a class-action racketeering lawsuit that alleged the skyrocketing price of the EpiPen, used by patients to mitigate severe allergic reactions, was the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 12, 2017 Category: Biotechnology Authors: Anne Stych Source Type: news

Strange new research claims thunderstorms may trigger asthma outbreaks
(Natural News) It may sound like a tenuous, even bizarre, connection but asthma and thunderstorms may be more connected than you think. New research from the University of Georgia suggested that asthma outbreaks may be triggered by thunderstorms, MedicineNet.com reported. The study, led by Professor of Geography Andrew Grundstein, explored the phenomenon of “thunderstorm asthma,” pointing to... (Source: NaturalNews.com)
Source: NaturalNews.com - May 12, 2017 Category: Consumer Health News Source Type: news

Stress-mitigation interventions for parents did not lessen symptoms among kids with asthma
(Children's National Health System) A $2.2 million, first-of-its kind randomized study found no differences between kids with asthma who received standard care based on National Institutes of Health guidelines compared with kids whose parents received stress-mitigation techniques in addition to evidence-based asthma care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2017 Category: International Medicine & Public Health Source Type: news

Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease
MONROVIA, Calif., May 11, 2017 -- (Healthcare Sales & Marketing Network) -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic d... Biopharmaceuticals, FDA Xencor, XmAb, IgG4-Related Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2017 Category: Pharmaceuticals Source Type: news